AILERON THERAPEUTICS INC

De la TradeVille.ro wiki
Versiunea din 29 septembrie 2024 05:02, autor: 127.0.0.1 (discuție) (The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles).)
(dif) ← Versiunea anterioară | Versiunea curentă (dif) | Versiunea următoare → (dif)

Pagina dedicata companiei AILERON THERAPEUTICS INC listata cu simbolul US.ALRN

Descriere companie[edit | ]

Aileron Therapeutics, Inc. (www.aileronrx.com) is a clinical-stage chemoprotection oncology company. The Company is focused on transforming the experience of chemotherapy for cancer patients. It is developing ALRN-6924, which is their dual Mouse double minute 2 homolog (MDM2) and MDMX inhibitor to provide a single medicine to protect multiple healthy cell types throughout the body from chemotherapy while ensuring chemotherapy continues to destroy cancer cells. ALRN-6924 acts as an agent to reduce the toxic side effects of chemotherapy in the bone marrow of cancer patients without adversely impacting the anti-cancer activity of chemotherapy against p53-mutant tumors.

Grafic actiuni companie[edit | ]

Ultimele stiri despre AILERON THERAPEUTICS INC (US.ALRN)[edit | ]

Adus de la „https://wiki.tradeville.ro/index.php?title=AILERON_THERAPEUTICS_INC&oldid=448007”